Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
- August -
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
- 2006 -
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
August 2006 - 31 products
L
SIP
IP
Aloxi
Durchstechflasche(n)
47.97
68.15
10 %
Injektionslösung: Palonosetronum
Medius AG
B / SL / SO
FB
G
IP
CI
Baraclude 0.5 mg
30 Tablette(n)
390.55
439.00
10 %
Filmtabletten: Entecavirum
Bristol-Myers Squibb SA
A / SL / SO
FB
G
L
IP
CI
Baraclude 1 mg
30 Tablette(n)
493.15
550.00
10 %
Filmtabletten: Entecavirum 1 mg
Bristol-Myers Squibb SA
A / SL / SO
FB
G
IP
CI
CM
Alfuzosine Uno Zentiva 10 mg
10 Tablette(n)
4.62
14.25
10 %
Retard-Tabletten: Alfuzosini Hydrochloridum 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Alfuzosine Uno Zentiva 10 mg
‐
I
30 Tablette(n)
13.14
30.70
10 %
Retard-Tabletten: Alfuzosini Hydrochloridum 10 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Alfuzosine Uno Zentiva 10 mg
‐
I
90 Tablette(n)
36.00
55.55
10 %
Retard-Tabletten: Alfuzosini Hydrochloridum 10 mg
Helvepharm AG
●
B / SL / SG
FB
G
IP
CI
Itraconazol Zentiva
4
5.03
14.70
10 %
Kapseln: Itraconazolum 100 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Itraconazol Zentiva
15
17.87
35.85
10 %
Kapseln: Itraconazolum 100 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Itraconazol Zentiva
30
35.74
55.25
10 %
Kapseln: Itraconazolum 100 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 1
30 Tablette(n)
1.64
11.00
10 %
Tabletten: Glimepiridum 1 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 1
120 Tablette(n)
5.63
15.35
10 %
Tabletten: Glimepiridum 1 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 2
-
T
30 Tablette(n)
2.84
12.30
10 %
Tabletten: Glimepiridum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 2
-
T
120 Tablette(n)
9.25
26.45
10 %
Tabletten: Glimepiridum 2 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 3
-
T
30 Tablette(n)
3.95
13.55
10 %
Tabletten: Glimepiridum 3 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 3
-
T
120 Tablette(n)
13.53
31.15
10 %
Tabletten: Glimepiridum 3 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 4
30 Tablette(n)
4.84
14.50
10 %
Tabletten: Glimepiridum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Glimepirid Sandoz 4
120 Tablette(n)
16.14
33.95
10 %
Tabletten: Glimepiridum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Kaletra 100/25
-
T
60 Tablette(n)
126.25
153.70
10 %
Filmtabletten: 2 Active Agents
AbbVie AG
A / SL
FB
G
IP
CI
Kaletra 200/50
-
T
120 Tablette(n)
504.99
565.60
10 %
Filmtabletten: 2 Active Agents
AbbVie AG
A / SL
FB
G
L
IP
CI
Sebivo 600 mg
28 Tablette(n)
411.72
464.20
10 %
Filmtabletten: Telbivudinum 600 mg
Viatris Pharma GmbH
A / SL
FB
G
IP
MAG-3 Kit
5 Durchstechflasche(n)
PR
502.15
10 %
Markierungsbesteck: Mertiatidum
medeo AG
A / SL
FB
G
L
SIP
IP
CI
Lucentis
Durchstechflasche(n) à 0.23 ml
611.09
677.60
10 %
Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
CI
Ph
CM
Echinarom
Erkältungskrankheiten
50 ml
11.38
21.00
10 %
Lösung: 3 Active Agents
Spagyros AG
D / SL
FB
G
CI
Ph
CM
Echinarom
Erkältungskrankheiten
100 ml
19.00
35.10
10 %
Lösung: 3 Active Agents
Spagyros AG
D / SL
FB
G
L
IP
V/S
Octaplex 500
Set(s)
273.82
322.00
10 %
Pulver und Lösungsmittel zur Herstellung einer Infusionslösung: 6 Active Agents
Octapharma AG
B / SL
FB
G
L
IP
V/S
Octaplex 1000
Set(s)
547.64
602.90
10 %
Pulver und Lösungsmittel zur Herstellung einer Infusionslösung: 6 Active Agents
Octapharma AG
B / SL
FB
G
IP
CI
Baraclude 0.05 mg/mL
210 ml
PR
PR
k.A.
Lösung (oral): Entecavirum
Bristol-Myers Squibb SA
A
FB
G
SIP
IP
CI
Lucentis
Durchstechflasche(n) à 0.23 ml
874.34
1020.15
k.A.
Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/ml
Novartis Pharma
Schweiz AG
B
FB
G
SIP
IP
CI
Lucentis
Durchstechflasche(n) à 0.23 ml
PR
PR
k.A.
Injektionslösung zur intravitrealen Injektion in Durchstechflasche: Ranibizumabum 10 mg/ml
Novartis Pharma
Schweiz AG
B
FB
G
CI
H
Herbalance
50 ml
PR
PR
k.A.
Tropfen zum Einnehmen: 4 Active Agents
Herbamed AG
D
FB
G
L
IP
Ciprofloxacin Sandoz
100 ml
10.63
20.40
10 %
Ciprofloxacinum 200 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
